1. Orlova M.A., Trofimova T.P., Orlov A.P., Shatalov O.A., Napolov Yu.K., Svistunov A.A., Chekhonin V.P. Antitumor activity of fullerene derivatives and their possible use for target drug delivery. Onkogematologija = Oncohematology, 2013, no. 2, pp. 83−92. https://doi.org/10.17650/1818-8346-2013-8-2-83-92 (in Russian).
2. Dikusar E. A., Pushkarchuk A. L., Bezyazychnaya T. V., Kasandrovich E. G., Soldatov A. G., Kuten S. A., Stepin S. G., Nizovtsev A. P., Kilin S. Ya. Tetracosehydroxybuckminsterfullerenol is a reagent of the future. Chemical reagents, reagents and processes of small-scale chemistry. - Abstracts of the XXXI International scientific and technical conference “React-2018”. - October 2-4, 2018, Minsk, Belarus. Minsk: Belarusian Science, 2018, p. 22 (in Russian).
3. Piotrovskiy L. B., Kiselev O. I. Fullerenes in biology. St. Petersburg, Rostock, 2006. 335 p. (in Russian).
4. Đorđević A., Bogdanović G. Fullerenol: A new nanopharmaceutic? Archive of Oncology, 2008, vol. 16, no. 3-4, pp. 42-45. https://doi.org/10.2298/AOO0804042D
5. Panova G. G., Kanash E. V., Semenov K. N., Charykov N. A., Khomyakov Yu. V., Anikina L. M., Artem’eva A. M., Kornyukhin D. L., Vertebnyi V. E., Sinyavina N. G., Udalova O. R., Kulenova N. A., Blokhina S. Yu. Fullerene derivatives stimulate the production process, growth and resistance to oxidative stress in wheat and barley plants. Sel’skohozjajstvennaja biologija = Agricultural Biology, 2018, vol. 53, no. 1, pp. 38-49. https://doi.org/10.15389/agrobiology.2018.1.38rus (in Russian).
6. Semenov K.N., Charykov N.A., Keskinov V.A. Fullerenol synthesis and identification. Rroperties of fullerenol water solutions. Journal of Chemical and Engineering Data, 2011, vol. 56, nn. 2, pp. 230-239. https://doi.org/https://pubs.acs.org/doi/10.1021/je100755v
7. Pushkarchuk A., Bezyazychnaya T., Potkin V., Dikusar E., Soldatov A., Kilin S., Nizovtsev A., Kuten S., Ermak D., Pushkarchuk V., Zhou H., Kulchitsky V. DFT Study of the Biological Activity of Fullerenol - Cisplatin Conjugate as an Antitumor Therapy Agent. Journal of Biomedical Research & Environmental Sciences, 2023, vol. 4, no. 2, pp. 179-183. https://doi.org/10.37871/jbres1661
8. Dikusar E. A., Pushkarchuk A. L., Bezyazychnaya T. V., Akishina E. A., Soldatov A. G., Kuten S. A., Stepin S. G., Nizovtsev A. P., Kilin S. Ya., Potkin V. I. Quantum-chemical modeling of cortisone-fullerenol agents of cancer therapy. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seryya khimichnykh navuk = Proceedings of the National Academy of Sciences of Belarus. Chemical Series, 2021, vol. 57, no. 4, pp. 400-407 https://doi.org/: https://doi.org/10.29235/1561-8331-2021-57-4-400-407 (in Russian).
9. Dikusar E. A., Pushkarchuk A. L., Bezyazychnaya T. V., Akishina E. A., Soldatov A. G., Kuten S. A., Stepin S. G., Nizovtsev A. P., Kilin S. Ya., Babichev L. F., Potkin V. I. Prospects for creating radon containing agents in radionuclide therapy. Vestnik farmacii = Pharmacy bulletin, 2021, no. 3 (93), pp. 64-72 (in Russian).
10. Dikusar E. A., Pushkarchuk A. L., Bezyazychnaya T. V., Akishina E. A., Soldatov A. G., Kuten S. A., Stepin S. G., Nizovtsev A. P., Kilin S. Ya., Kulchitsky V. A., Potkin V. I. Quantum-chemical modeling of doxorubicino-fullerenol agents of cancer therapy. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seryya khimichnykh navuk = Proceedings of the National Academy of Sciences of Belarus. Shemical series, 2022, vol. 58, no. 4, pp. 369-378 (in Russian).
11. Charkin O. P., Klimenko N. M., Wang Y.-S., Wang C.-C., Chen C.-H., Lin S. H. Theoretical and experimental study of fullerenol molecules and ions C60(OH)24-N (OL)N and C60(OH)24-N(OL)N L+ successively substituted by alkali metal atoms l (N = 1-24). Zhurnal neorganicheskoj himii = Russian journal of inorganic chemistry, 2011, vol. 56, no. 4, pp. 623-633 (in Russian).